.ALX Oncology's period 2 gastric cancer reaction rate has damaged. After viewing its CD47 blocker si...
.Yet Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of expectations, promp...
.While Biogen's pharma peers are actually looking for late-stage possessions along with little risk,...
.Instil Bio has been a biotech looking for a pipeline after it ditched its own lead assets over the ...
.Biogen has actually restored rights to a very early Alzheimer's condition plan to Denali Rehabs, le...
.Accept to today's Chutes & Ladders, our summary of considerable leadership hirings, firings as w...
.Vertex's try to treat a rare hereditary illness has reached an additional trouble. The biotech toss...
.Vir Biotechnology's second-quarter profits file had not been short of large information. The firm w...
.Galapagos has actually stopped application in a trial of a BCMA-directed CAR-T tissue therapy, push...
.After greater than three decades, gene therapy trailblazer James Wilson M.D., Ph.D., is leaving the...